Equifax (NYSE:EFX) Issues FY 2024 Earnings Guidance

Equifax (NYSE:EFX) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 7.250-7.350 for the period, compared to the consensus estimate of 7.360. The company issued revenue guidance of $5.7 billion-$5.7 billion, compared to the consensus revenue estimate of $5.7 billion. Equifax also updated its FY24 guidance to $7.25-7.35 EPS.

Analyst Ratings Changes

EFX has been the topic of a number of recent analyst reports. UBS Group assumed coverage on Equifax in a report on Tuesday, October 1st. They issued a “buy” rating and a $360.00 price objective on the stock. Wells Fargo & Company raised their price objective on shares of Equifax from $340.00 to $375.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Morgan Stanley upped their target price on shares of Equifax from $250.00 to $271.00 and gave the company an “equal weight” rating in a report on Thursday, September 12th. Bank of America lifted their price target on shares of Equifax from $255.00 to $286.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Finally, Oppenheimer boosted their price target on shares of Equifax from $300.00 to $315.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Four research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $307.74.

Equifax Stock Down 0.1 %

EFX stock opened at $289.95 on Thursday. The stock has a market capitalization of $35.84 billion, a PE ratio of 64.58, a price-to-earnings-growth ratio of 2.00 and a beta of 1.58. The company has a fifty day moving average of $294.89 and a 200-day moving average of $262.68. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.79 and a current ratio of 0.79. Equifax has a one year low of $159.95 and a one year high of $309.63.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, October 16th. The credit services provider reported $1.85 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. Equifax had a net margin of 10.67% and a return on equity of 18.88%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter last year, the firm earned $1.76 earnings per share. The firm’s revenue was up 9.3% compared to the same quarter last year. As a group, analysts expect that Equifax will post 7.36 EPS for the current year.

Equifax Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 13th. Investors of record on Tuesday, September 3rd were issued a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a yield of 0.54%. The ex-dividend date of this dividend was Tuesday, September 3rd. Equifax’s dividend payout ratio is presently 34.74%.

Insiders Place Their Bets

In other Equifax news, EVP Carla Chaney sold 3,000 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $281.85, for a total transaction of $845,550.00. Following the sale, the executive vice president now directly owns 10,875 shares in the company, valued at approximately $3,065,118.75. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.57% of the stock is currently owned by company insiders.

About Equifax

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.